Evaluation of Rectal Cancer Treatment Response Using PET/MRI

NCT02233595 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2019-08-13

No results posted yet for this study

Summary

The investigators will be using the combination of FDG-PET and multiparametric MRI in pre- and post-adjuvant chemoradiation therapy in order to attempt to predict pathologic response on surgical resection.

Conditions

  • Rectal Adenocarcinoma

Interventions

RADIATION

Chemoradiation

Sponsors & Collaborators

Principal Investigators

  • Thomas Hope, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-15
Primary Completion
2018-01-28
Completion
2018-01-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02233595 on ClinicalTrials.gov